NextBio receives phase II SBIR grant to add new genomic and proteomic content

NextBio has announced the receipt of a Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH).

The grant will provide approximately $1,000,000 over two years to support the incorporation of genomic and proteomic information from additional vertebrate organisms into NextBio. It will also help fund NextBio's development of infrastructure to support plant research by incorporating Arabidopsis, corn, rice and soy plant genomics into its cross-species knowledge discovery framework.

"Life science researchers use critical biological information from studies of diverse species to make key correlations that help them discover new knowledge about human or plant physiology and disease," said Saeid Akhtari, NextBio President and Chief Executive Officer. "With this support from NIH, we will extend the NextBio offering enabling researchers to leverage a wider range of data from model organisms to better understand biology."

As part of this effort, NextBio will develop ontologies, translational methodology and cross-study comparison logic to connect findings across different organisms. Furthermore, the company will develop advanced statistical and visualization methods to help correlate and interpret the data. The new species information will build upon a wealth of information already supported within NextBio from human, mouse, rat, fly, worm and yeast systems.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Dietary vitamin A shows promise in Alzheimer's disease intervention, study finds